Absci Corporation (ABSI)
NASDAQ
Closed
Sep 18, 2026
Day's Range
9.0852 wk Range
2.24Overview - ABSI - Absci Corporation
Key Statistics
Valuation
Enterprise Value
1.39B
P/E (Trailing)
‪-11.50‬
P/E (Forward)
‪-13.73‬
PEG Ratio
‪0.92‬
Price / Sales (TTM)
‪1,019.13‬
Price / Book
‪6.45‬
EV / EBITDA
‪-11.66‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-10,741.50%‬
Return on Assets
‪-34.09%‬
Return on Equity
‪-57.72%‬
Ownership
Shares Outstanding
171.55M
Float
163.79M
Short % of Shares Outstanding
‪26.08%‬
Held by Insiders
‪11.84%‬
Held by Institutions
‪87.22%‬
Price stats
Beta
‪2.43‬
50-Day Avg
‪8.82‬
200-Day Avg
‪5.46‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
10 analysts
Average price target
‪$ 13.89‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ABSI - Absci Corporation
Peers - ABSI - Absci Corporation
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ABSINASDAQAbsci Corporation1.65BMarket Cap+72.95%52-week change-11.51P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQArgenx SE61.58BMarket Cap+25.27%52-week change37.92P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.32.05BMarket Cap-91.57%52-week change41.68P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE24.13BMarket Cap-2.77%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S15.57BMarket Cap+17.02%52-week change18.34P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.02BMarket Cap+22.62%52-week change-17.62P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.12.37BMarket Cap+15.64%52-week change172.81P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ABSI - Absci Corporation
About
Absci Corporation is a clinical-stage biopharmaceutical company focused on discovering and designing protein-based therapeutics using generative artificial intelligence and synthetic biology. Absci integrates AI-driven modeling with high-throughput wet lab capabilities to create antibody and other biologic candidates…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
